PUMA BIOTECHNOLOGY, INC. Total Liabilities
PUMA BIOTECHNOLOGY, INC. (PBYI) had Total Liabilities of $54.19 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $54.19M.
- 2026-03-31: Liabilities $64.28M.
- 2025-12-31: Liabilities $85.96M.
- 2025-09-30: Liabilities $87.59M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $54.19M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $64.28M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $85.96M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $87.59M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $90.20M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $99.07M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $121.21M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $149.63M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $156.49M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $163.17M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $177.09M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $164.86M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $170.09M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $170.41M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $200.45M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $176.62M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $173.91M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $193.54M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $229.03M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $237.21M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $230.53M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $242.22M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $250.17M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $262.15M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $240.41M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $216.15M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $217.44M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $214.86M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $218.09M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $287.88M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $224.82M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $184.81M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $189.32M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $112.18M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $112.22M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $102.69M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $52.71M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $49.23M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $42.97M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $42.88M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $43.81M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $40.23M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $33.84M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $26.78M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $27.58M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $27.55M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $45.71M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $30.45M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $29.04M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $21.47M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $20.39M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $20.35M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $20.96M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $22.74M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $22.79M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $27.49M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $16.40M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $10.23M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.03M 10-K · filed 2013-04-01 | $1.03M 10-K · filed 2012-03-29 |
| 2011-09-30 | $362.05K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.28K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |